Posts by: Iqra Mumal

News

In what could be the first step on the long road to finding a potential cure, researchers have found that aberrations in RNA processing are the major cause of ... Read more

August 28, 2017August 28, 2017

Researchers Isolate ST2 Protein as Potential Biomarker for Heart Disease in Duchenne Muscular Dystrophy

News

Researchers have found Duchenne muscular dystrophy (DMD) patients with heart disease have very high levels of ST2, an interleukin 1 receptor-like 1 protein. That makes this molecule a potential biomarker ... Read more

August 14, 2017

Researchers Develop Newborn Screening Tool for Duchenne

News

Cardiff University scientists, partnering with the biotech company PerkinElmer, have developed a diagnostic kit to screen for Duchenne muscular dystrophy (DMD) in newborns using dried blood spots, according to researchers. The ... Read more

July 14, 2017

FDA Grants Orphan Designation to Mallinckrodt’s MNK-1411 for DMD

News

The U.S. Food and Drug Administation has granted orphan designation to Mallinckrodt Pharmaceuticals‘ drug candidate MNK-1411 for treatment of Duchenne Muscular Dystrophy (DMD). MNK-1411 is an injection composed of a formulation ... Read more

July 12, 2017July 12, 2017

Problems in RNA Processing Seen to Lead to Congenital Myotonic Dystrophy in Early Study

News

The molecular process that leads to congenital myotonic dystrophy (CMD) in infants and children was identified by researchers working with tissue samples and mice. Their study, titled “Disrupted prenatal RNA processing and ... Read more